ITOS: מחיר למכירות iTeos Therapeutics Inc

iTeos Therapeutics (ITOS) operates in the advanced immuno-oncology segment with high growth potential. The price/sales multiple on this GURU.Markets chart helps track the gap between quotes and revenues, where the value of 11.00 represents the current figure. Market capitalization relies on payments from GSK for the joint development of antibodies, while revenues are based on research milestone bonuses and future royalties.
פילוחי מדדים ואנליטיקה של חברת iTeos (ITOS)

Analyzing the P/S volatility of iTeos Therapeutics (ITOS), an investor assesses the business's market value relative to its annual turnover, which determines the company's resilience to industry shocks. This ratio compares total capitalization with revenue, reflecting the extent to which the proprietary antibody immuno-oncology platform and the B2B development patent perimeter justify current market expectations compared to sector averages.